NeuronAlgo
~/backtests/na-nas-l-017 backtest

$ cd /evidence  ·  evidence archive

Backtest evidence

Menkent

code: NA-NAS-L-017 NasdaQ_Oanda H1 2006-01-02 → 2026-06-19
net $11,725 trades 460 win 50.22%
at-a-glance --summaryok

$ stats --glance

headline performance at a glance

net_profit
Total net profit $11,725
gross profit$47,170
gross loss$35,445
win_rate
50.22%WIN
█████░░░░░
Win rate
231W / 229L
profit_factor
1.33PF
████░░░░░░
Profit factor
gross P / gross L
cagr
3.96%CAGR
░░░░░░░░░
CAGR
annualized
max_drawdown
-20.78%MAX DD
██░░░░░░░░
Max drawdown
$2,203
equity_curve --renderok

$ plot --equity

cumulative account equity over the test window

Stored snapshot: 920 points; starts at $10,000.00, ends at $21,725.46; observed range $7,922.34–$21,725.46.

x: time · y: equity (USD)● rendered by na-backtest-charts

$ plot --drawdown

underwater equity (peak-to-trough), in account currency — risk per trade is a fixed dollar amount, so a percent axis would shrink every year as the balance grew

x: time · y: drawdown (USD)● rendered by na-backtest-charts
trade_breakdown --analyzepartial

$ trades --breakdown

win/loss split, averages, and streaks

win_loss_split
50.22%win
Wins231
Losses229
Total460
win_vs_loss_size
Avg win$204.20
Avg loss$154.78
Largest win$741.42
Largest loss-$217.60
key_ratios
Profit factor1.33
Win/Loss ratio1.01
Payout ratio1.32
Expectancy$25.49
Avg trade$25.49
Bars in trade28.60
streaks
Max consec wins8
Max consec losses10
Avg consec wins1.00
Avg consec losses1.00
Long vs short breakdown and per-trade distributions are not in the ingested dataset yet.
full_statistics --allok

$ stats --full

complete metric set, grouped by category

$11,725
Net profit
$47,170
Gross profit
$35,445
Gross loss
3.96%
CAGR
5.58
AHPR
$586
Yearly avg profit
$48
Monthly avg profit
$1.57
Daily avg profit
5.86%
Yearly avg return
13.69%
Exposure
460
Trades
$25.49
Avg trade
run.configok

$ cat run.config

parameters used for this run

instrumentNasdaQ_Oanda
timeframeH1
period start2006-01-02
period end2026-06-19
profit in pips154601.02 ticks
strategyview →
Trading financial instruments carries a high level of risk and may not be suitable for all investors. Past performance — including backtested and simulated results — is not indicative of future results. NeuronAlgo provides research and tooling, not financial advice.
nextok

Explore the strategy behind this run

See the full methodology, risk profile, and live track record — or browse every backtest in the library.

Generated from stored backtest metrics · NeuronAlgo research desk

Scroll to Top